Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0XD4N
|
||||
| Former ID |
DIB008256
|
||||
| Drug Name |
ERB-002
|
||||
| Synonyms |
ERB-002; ERB-131; ERb agonists, ACADIA; Estrogen receptor beta agonists, ACADIA
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543899] | ||
| Company |
ACADIA Pharmaceuticals Inc
|
||||
| Canonical SMILES |
C1CC(CCC1)(c1ccc(cc1)O)c1ccccc1
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor beta | Target Info | Agonist | [543899] | |
| KEGG Pathway | Estrogen signaling pathway | ||||
| Prolactin signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.